Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
C$0.00
C$0.85
▼
C$4.97
C$38.72M2.13253,024 shs72,643 shs
Medicure Inc. stock logo
MPH
Medicure
C$3.51
-6.4%
C$3.44
C$0.85
▼
C$4.95
C$36.63M1.0157334,513 shs6,627 shs
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
C$0.00
C$0.14
▼
C$4.74
C$15.73MN/A92,998 shs10,366 shs
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.15
-1.1%
$11.07
$5.32
▼
$14.38
$1.57B1.72.46 million shs2.15 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
Medicure Inc. stock logo
MPH
Medicure
-0.79%+1.35%-11.76%+188.46%+190.70%
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
0.00%0.00%0.00%0.00%0.00%
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-3.44%-29.66%-7.13%-5.32%+68.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
C$0.00
C$0.85
▼
C$4.97
C$38.72M2.13253,024 shs72,643 shs
Medicure Inc. stock logo
MPH
Medicure
C$3.51
-6.4%
C$3.44
C$0.85
▼
C$4.95
C$36.63M1.0157334,513 shs6,627 shs
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
C$0.00
C$0.14
▼
C$4.74
C$15.73MN/A92,998 shs10,366 shs
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.15
-1.1%
$11.07
$5.32
▼
$14.38
$1.57B1.72.46 million shs2.15 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
Medicure Inc. stock logo
MPH
Medicure
-0.79%+1.35%-11.76%+188.46%+190.70%
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
0.00%0.00%0.00%0.00%0.00%
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-3.44%-29.66%-7.13%-5.32%+68.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
0.00
N/AN/AN/A
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
0.00
N/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2.78
Moderate Buy$22.57146.68% Upside

Current Analyst Ratings Breakdown

Latest NEPT, MPH, HEXO, and VIR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Boost Price TargetOverweight$25.00 ➝ $28.00
11/9/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Reiterated RatingBuy$22.00
11/5/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Boost Price TargetBuy$18.00 ➝ $20.00
11/4/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
UpgradeStrong Sell ➝ Hold
10/7/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Boost Price TargetBuy$20.00 ➝ $22.00
10/6/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
DowngradeHold ➝ Strong Sell
10/2/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Reiterated RatingSell (D-)
9/28/2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Reiterated RatingStrong-Buy
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HEXO Corp. stock logo
HEXO
HEXO
C$124.10M0.00N/A1.55C$3.24 per share0.00
Medicure Inc. stock logo
MPH
Medicure
C$32.08M1.14C$1.41 per share2.49C$1.11 per share3.17
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
C$48.80M0.00N/A1.71C$8.66 per share0.00
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$68.56M22.86N/AN/A$5.23 per share1.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HEXO Corp. stock logo
HEXO
HEXO
-C$273.18M-C$3.41N/AN/A-220.13%-106.39%-14.96%N/A
Medicure Inc. stock logo
MPH
Medicure
-C$2.03M-C$0.72N/AN/AN/A-23.23%-54.73%-5.63%N/A
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
N/A-C$24.16N/AN/AN/AN/AN/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-$437.99M-$1.26N/AN/AN/AN/A-21.38%-16.97%N/A

Latest NEPT, MPH, HEXO, and VIR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-$0.7493-$0.57+$0.1793-$0.57$0.98 million($0.19) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/A2.24%N/AN/AN/A
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HEXO Corp. stock logo
HEXO
HEXO
125.99
0.41
0.40
Medicure Inc. stock logo
MPH
Medicure
6.02
0.97
1.29
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
23.59
1.23
0.54
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
N/A
6.30
6.30

Institutional Ownership

CompanyInstitutional Ownership
HEXO Corp. stock logo
HEXO
HEXO
7.57%
Medicure Inc. stock logo
MPH
Medicure
4.85%
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
N/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
65.32%

Insider Ownership

CompanyInsider Ownership
HEXO Corp. stock logo
HEXO
HEXO
3.03%
Medicure Inc. stock logo
MPH
Medicure
26.68%
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
N/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
HEXO Corp. stock logo
HEXO
HEXO
69044.00 millionN/ANot Optionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.44 millionN/ANot Optionable
Neptune Wellness Solutions Inc. stock logo
NEPT
Neptune Wellness Solutions
1307.99 millionN/ANot Optionable
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
367171.27 million166.30 millionOptionable

Recent News About These Companies

Why is Vir Biotechnology stock falling Friday?
Vir Biotechnology stock tumbles on $150M share offering
HC Wainwright Has Optimistic Opinion of VIR FY2026 Earnings
Vir Biotechnology Announces Proposed Public Offering
TD Cowen Reaffirms Their Buy Rating on Vir Biotechnology (VIR)
Is Vir Biotechnology (VIR) Overvalued After Its 127% Run?
What is HC Wainwright's Estimate for VIR FY2026 Earnings?
Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from HC Wainwright

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HEXO stock logo

HEXO TSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

Medicure stock logo

Medicure CVE:MPH

C$3.51 -0.24 (-6.40%)
As of 03:35 PM Eastern

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Neptune Wellness Solutions stock logo

Neptune Wellness Solutions TSE:NEPT

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Vir Biotechnology stock logo

Vir Biotechnology NASDAQ:VIR

$9.15 -0.10 (-1.08%)
Closing price 04:00 PM Eastern
Extended Trading
$9.18 +0.03 (+0.28%)
As of 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.